Alterity Therapeutics (PRNAD) Return on Invested Capital (2016 - 2019)

Alterity Therapeutics (PRNAD) has reported Return on Invested Capital for 4 consecutive years, with 0.05% the latest figure, recorded in Q4 2019.

• In Q4 2019, Return on Invested Capital rose 7.0% year-over-year to 0.05%; the TTM figure through Dec 2019 stood at 0.05% (up 7.0% YoY), while the FY2023 annual figure was 7604.62%, down 760461.0% from the prior year.
• Return on Invested Capital came in at 0.05% for Q4 2019 at Alterity Therapeutics, up from 0.12% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.09% in Q4 2016, with the low at 0.12% in Q4 2018.
• Average Return on Invested Capital over 4 years is 0.02%, with a median of 0.02% recorded in 2017.
• Across the five-year window, Return on Invested Capital decreased 14 bps in 2018 and advanced 7 bps in 2019, its largest moves.
• Year by year, Return on Invested Capital stood at 0.09% in 2016, then tumbled by 81 bps to 0.02% in 2017, then tumbled by 847 bps to 0.12% in 2018, then soared by 55 bps to 0.05% in 2019.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.05%, 0.12%, and 0.02% for Q4 2019, Q4 2018, and Q4 2017 respectively.